Thursday May 25th 2017

FAQ

FAQ

  1. What is CCSVI?
  2. Why is there a sudden interest in CCSVI and MS?
  3. Do these reports of a possible association between insufficient vein drainage and MS mean that MS is caused by venous insufficiency?
  4. How has CCSVI been treated?
  5. What are the potential complications for this procedure?
  6. Can I be tested or treated for CCSVI right now?
  7. Will the treatment of CCSVI be useful for the various forms of MS?
  8. What are the next steps to study the CCSVI hypothesis?
  9. How much time and funding are needed to study the CCSVI hypothesis?

Latest Topics

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care [Read More]

Roche investigating case of patient illness after taking MS drug

Roche investigating case of patient illness after taking MS drug

ZURICH (Reuters) - A person in Germany treated with Roche ’s new multiple sclerosis drug Ocrevus has been diagnosed [Read More]

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]